Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

S&P Pharmaceuticals SPDR (XPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family State Street Global Advisors
  • Assets Under Management 247,695,200
  • Market Capitalization, $K 247,695
  • Shares Outstanding, K 6,050
  • 36-Month Beta 1.37
  • Price/Book 2.23
  • Price/Earnings ttm 10.87
  • Annual Dividend & Yield 0.24 (0.57%)
  • Most Recent Dividend 0.106 on 12/24/18
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.97 +7.01%
on 01/29/19
41.75 -0.12%
on 02/15/19
+1.85 (+4.64%)
since 01/15/19
3-Month
34.51 +20.83%
on 12/24/18
44.12 -5.49%
on 12/04/18
-1.53 (-3.54%)
since 11/15/18
52-Week
34.51 +20.83%
on 12/24/18
49.97 -16.55%
on 08/31/18
-1.56 (-3.61%)
since 02/15/18

Most Recent Stories

More News
A Look at Pharma ETFs Post Q4 Results

The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month.

XPH : 41.70 (+1.04%)
IHE : 152.24 (+1.40%)
PJP : 67.41 (+1.28%)
PPH : 60.96 (+1.20%)
FTXH : 21.24 (+0.87%)
A Look at Pharma ETFs Post Q4 Results

The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month.

XPH : 41.70 (+1.04%)
IHE : 152.24 (+1.40%)
PJP : 67.41 (+1.28%)
PPH : 60.96 (+1.20%)
FTXH : 21.24 (+0.87%)
4 Top-Ranked Undervalued Sector ETFs to Buy in 2019

These sector ETFs could gain in 2019 on lower valuation.

XPH : 41.70 (+1.04%)
FXU : 28.03 (+1.19%)
FXD : 41.83 (+0.92%)
FCOM : 31.65 (+0.73%)
SPY : 277.37 (+1.09%)
4 Top-Ranked Undervalued Sector ETFs to Buy in 2019

These sector ETFs could gain in 2019 on lower valuation.

XPH : 41.70 (+1.04%)
FXU : 28.03 (+1.19%)
FXD : 41.83 (+0.92%)
FCOM : 31.65 (+0.73%)
SPY : 277.37 (+1.09%)
5 Incredible ETFs & Stocks to Buy on the Dip

The dips might charge up investors to snap up stocks and ETFs on the cheap for outsized gains heading into Christmas.

XPH : 41.70 (+1.04%)
KEM : 19.06 (+1.28%)
FXU : 28.03 (+1.19%)
UNM : 36.32 (+2.63%)
KIE : 31.42 (+1.55%)
SPVU : 34.51 (+1.57%)
SNE : 45.79 (+1.48%)
FCOM : 31.65 (+0.73%)
MFC : 16.23 (+1.18%)
SPY : 277.37 (+1.09%)
BIIB : 332.87 (+2.51%)
5 Incredible ETFs & Stocks to Buy on the Dip

The dips might charge up investors to snap up stocks and ETFs on the cheap for outsized gains heading into Christmas.

XPH : 41.70 (+1.04%)
KEM : 19.06 (+1.28%)
FXU : 28.03 (+1.19%)
UNM : 36.32 (+2.63%)
KIE : 31.42 (+1.55%)
SPVU : 34.51 (+1.57%)
SNE : 45.79 (+1.48%)
FCOM : 31.65 (+0.73%)
MFC : 16.23 (+1.18%)
SPY : 277.37 (+1.09%)
BIIB : 332.87 (+2.51%)
Midterms Produce Split Congress: ETF Areas in Focus

These ETF investing areas may see some changes in the coming days as midterms delivered a split congress.

EWC : 27.41 (+1.33%)
XPH : 41.70 (+1.04%)
XHS : 71.56 (+1.04%)
IYC : 199.66 (+0.77%)
EWW : 43.79 (+0.99%)
XLI : 75.69 (+1.34%)
VIG : 108.43 (+1.47%)
FXI : 42.63 (-0.54%)
DVY : 97.04 (+0.68%)
DIA : 258.65 (+1.37%)
Midterms Produce Split Congress: ETF Areas in Focus

These ETF investing areas may see some changes in the coming days as midterms delivered a split congress.

EWC : 27.41 (+1.33%)
XPH : 41.70 (+1.04%)
XHS : 71.56 (+1.04%)
IYC : 199.66 (+0.77%)
EWW : 43.79 (+0.99%)
XLI : 75.69 (+1.34%)
VIG : 108.43 (+1.47%)
FXI : 42.63 (-0.54%)
DVY : 97.04 (+0.68%)
DIA : 258.65 (+1.37%)
Beaten-Down Pharma ETFs to Buy Post Q3 Results

Despite strong results, the broad market sell-off took the sheen from the pharma ETFs over the past month. These funds have a Zacks ETF Rank #2 (Buy), suggesting solid entry point on beaten down prices....

XPH : 41.70 (+1.04%)
MRK : 79.81 (+1.10%)
JNJ : 136.38 (+1.54%)
IHE : 152.24 (+1.40%)
PJP : 67.41 (+1.28%)
PPH : 60.96 (+1.20%)
PFE : 42.40 (+1.02%)
BMY : 51.67 (+1.65%)
FTXH : 21.24 (+0.87%)
Beaten-Down Pharma ETFs to Buy Post Q3 Results

Despite strong results, the broad market sell-off took the sheen from the pharma ETFs over the past month. These funds have a Zacks ETF Rank #2 (Buy), suggesting solid entry point on beaten down prices....

XPH : 41.70 (+1.04%)
MRK : 79.81 (+1.10%)
JNJ : 136.38 (+1.54%)
IHE : 152.24 (+1.40%)
PJP : 67.41 (+1.28%)
PPH : 60.96 (+1.20%)
PFE : 42.40 (+1.02%)
BMY : 51.67 (+1.65%)
FTXH : 21.24 (+0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade XPH with:

Fund Summary

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 41.92
1st Resistance Point 41.81
Last Price 41.70
1st Support Level 41.53
2nd Support Level 41.36

See More

52-Week High 49.97
Fibonacci 61.8% 44.06
Fibonacci 50% 42.24
Last Price 41.70
Fibonacci 38.2% 40.42
52-Week Low 34.51

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar